Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
07/11/2025
The Governor of the Bank of Canada's opening remarks at the Senate committee were completely consistent with his remarks in the House of Commons on Wednesday.
Latest
2 m ago
Nord and Nord: Negotiations under the framework of the White House agreement and the "Lowering Inflation Act" are independent of each other.
2 m ago
The US government, Eli Lilly and Novo Nordisk announced an agreement to lower the price of GLP-1 weight loss drugs. Both companies will price it at $245 per month.
3 m ago
Rei Lai Company: According to the agreement, the cost for self-paying patients to purchase the lowest dose version of Zepbound is $299, and the cost for higher dose versions is $449 per month.
3 m ago
Rey Pharmaceutical Company: If its experimental drug Ofgalapril tablet is approved, it will implement a low-price strategy.
3 m ago
Lilly Corporation: Will be adding the diabetes drugs EMGALITY, TRULICITY, and MOUNJARO to its website that directly targets consumers, priced 50%-60% lower than the standard price.
See all latest